Ironwood Pharmaceuticals Inc
IRWD· Nasdaq
Released Oct 31, 2019, before the open
10-Q filed Oct 31, 2019, 31 days after period end · 0001558370-19-009567
| Metric | Q3 2019 | Q3 2018 | Q3 2017 | Q3 2016 |
|---|---|---|---|---|
| Revenue | $131.17M | $65.69M | $86.83M | $66.11M |
| Net Income | $20.65M | -$174.35M | -$32.30M | -$33.20M |
| EPS Diluted |
Ironwood Pharmaceuticals Inc · CIK 1446847 · Engraved from SEC EDGAR
| $0.13 |
| -$1.14 |
| -$0.22 |
| -$0.23 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.